<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Meeting id="1662540" title="Neratinib after adjuvant chemotherapy and trastuzumab in HER2-positive early breast cancer: Primary analysis at 2 years of a phase 3, randomized, placebo-controlled trial (ExteNET)"><ConferenceName>51st American Society of Clinical Oncology Annual Meeting</ConferenceName><StartDate>2015-05-29T00:00:00Z</StartDate><EndDate>2015-06-02T00:00:00Z</EndDate><City>Chicago</City><Country>US</Country></Meeting>